Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation

Abstract Immunotherapies targeting pathological tau have recently emerged as a promising approach for treatment of neurodegenerative disorders. We have previously showed that the mouse antibody DC8E8 discriminates between healthy and pathological tau, reduces tau pathology in murine tauopathy models...

Full description

Bibliographic Details
Main Authors: Monika Zilkova, Anna Nolle, Branislav Kovacech, Eva Kontsekova, Petronela Weisova, Peter Filipcik, Rostislav Skrabana, Michal Prcina, Tomas Hromadka, Ondrej Cehlar, Gabriela Paulikova Rolkova, Denisa Maderova, Michal Novak, Norbert Zilka, Jeroen J. M. Hoozemans
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Acta Neuropathologica Communications
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40478-020-00948-z
_version_ 1818109525965668352
author Monika Zilkova
Anna Nolle
Branislav Kovacech
Eva Kontsekova
Petronela Weisova
Peter Filipcik
Rostislav Skrabana
Michal Prcina
Tomas Hromadka
Ondrej Cehlar
Gabriela Paulikova Rolkova
Denisa Maderova
Michal Novak
Norbert Zilka
Jeroen J. M. Hoozemans
author_facet Monika Zilkova
Anna Nolle
Branislav Kovacech
Eva Kontsekova
Petronela Weisova
Peter Filipcik
Rostislav Skrabana
Michal Prcina
Tomas Hromadka
Ondrej Cehlar
Gabriela Paulikova Rolkova
Denisa Maderova
Michal Novak
Norbert Zilka
Jeroen J. M. Hoozemans
author_sort Monika Zilkova
collection DOAJ
description Abstract Immunotherapies targeting pathological tau have recently emerged as a promising approach for treatment of neurodegenerative disorders. We have previously showed that the mouse antibody DC8E8 discriminates between healthy and pathological tau, reduces tau pathology in murine tauopathy models and inhibits neuronal internalization of AD tau species in vitro. Here we show, that DC8E8 and antibodies elicited against the first-in-man tau vaccine, AADvac1, which is based on the DC8E8 epitope peptide, both promote uptake of pathological tau by mouse primary microglia. IgG1 and IgG4 isotypes of AX004, the humanized versions of DC8E8, accelerate tau uptake by human primary microglia isolated from post-mortem aged and diseased brains. This promoting activity requires the presence of the Fc-domain of the antibodies. The IgG1 isotype of AX004 showed greater ability to promote tau uptake compared to the IgG4 isotype, while none of the antibody-tau complexes provoked increased pro-inflammatory activity of microglia. Our data suggest that IgG1 has better suitability for therapeutic development.
first_indexed 2024-12-11T02:32:39Z
format Article
id doaj.art-a4c9386438824459a38b0c854273aacf
institution Directory Open Access Journal
issn 2051-5960
language English
last_indexed 2024-12-11T02:32:39Z
publishDate 2020-05-01
publisher BMC
record_format Article
series Acta Neuropathologica Communications
spelling doaj.art-a4c9386438824459a38b0c854273aacf2022-12-22T01:23:49ZengBMCActa Neuropathologica Communications2051-59602020-05-018111910.1186/s40478-020-00948-zHumanized tau antibodies promote tau uptake by human microglia without any increase of inflammationMonika Zilkova0Anna Nolle1Branislav Kovacech2Eva Kontsekova3Petronela Weisova4Peter Filipcik5Rostislav Skrabana6Michal Prcina7Tomas Hromadka8Ondrej Cehlar9Gabriela Paulikova Rolkova10Denisa Maderova11Michal Novak12Norbert Zilka13Jeroen J. M. Hoozemans14Axon Neuroscience R&D Services SEAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Amsterdam NeuroscienceAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience R&D Services SEAxon Neuroscience SEAxon Neuroscience R&D Services SEAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Amsterdam NeuroscienceAbstract Immunotherapies targeting pathological tau have recently emerged as a promising approach for treatment of neurodegenerative disorders. We have previously showed that the mouse antibody DC8E8 discriminates between healthy and pathological tau, reduces tau pathology in murine tauopathy models and inhibits neuronal internalization of AD tau species in vitro. Here we show, that DC8E8 and antibodies elicited against the first-in-man tau vaccine, AADvac1, which is based on the DC8E8 epitope peptide, both promote uptake of pathological tau by mouse primary microglia. IgG1 and IgG4 isotypes of AX004, the humanized versions of DC8E8, accelerate tau uptake by human primary microglia isolated from post-mortem aged and diseased brains. This promoting activity requires the presence of the Fc-domain of the antibodies. The IgG1 isotype of AX004 showed greater ability to promote tau uptake compared to the IgG4 isotype, while none of the antibody-tau complexes provoked increased pro-inflammatory activity of microglia. Our data suggest that IgG1 has better suitability for therapeutic development.http://link.springer.com/article/10.1186/s40478-020-00948-zTau immunotherapyHumanized antibodyHuman microgliaTau uptake
spellingShingle Monika Zilkova
Anna Nolle
Branislav Kovacech
Eva Kontsekova
Petronela Weisova
Peter Filipcik
Rostislav Skrabana
Michal Prcina
Tomas Hromadka
Ondrej Cehlar
Gabriela Paulikova Rolkova
Denisa Maderova
Michal Novak
Norbert Zilka
Jeroen J. M. Hoozemans
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
Acta Neuropathologica Communications
Tau immunotherapy
Humanized antibody
Human microglia
Tau uptake
title Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
title_full Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
title_fullStr Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
title_full_unstemmed Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
title_short Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
title_sort humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
topic Tau immunotherapy
Humanized antibody
Human microglia
Tau uptake
url http://link.springer.com/article/10.1186/s40478-020-00948-z
work_keys_str_mv AT monikazilkova humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT annanolle humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT branislavkovacech humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT evakontsekova humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT petronelaweisova humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT peterfilipcik humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT rostislavskrabana humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT michalprcina humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT tomashromadka humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT ondrejcehlar humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT gabrielapaulikovarolkova humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT denisamaderova humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT michalnovak humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT norbertzilka humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation
AT jeroenjmhoozemans humanizedtauantibodiespromotetauuptakebyhumanmicrogliawithoutanyincreaseofinflammation